Assistance Publique Hopitaux de Marseille
Marseille, France
NCT Number: NCT01116765
To assess whether an oral stimulation program, before the introduction of oral feeding, enhances the cardiorespiratory manifestations (episodes of oxygen désaturations, and/or apnea- bradycardia), and the oral feeding performance, in preterm infants born between 26 to 29 weeks of gestation age.
Looking for future studies?
Notify Me29 week–33 week
All sexes
Interventional
Not applicable
Marseille, France
Preterm infant were randomized into an experimental or an control group. Infants in the experimental group receive an oral stimulation program consisting of stimulation of the oral structures during 10 consecutive days. Infant in the control group receive no stimulation only non nutritive sucking during feeding. Both were administered twice per day, during 20 minutes, 48 hours after discontinuation of nasal continuous positive air pressure. A long term evaluation of oral feeding difficulties and neuromotor development are organized.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
to assess whether an oral stimulation program, before the introduction of oral feeding, enhances the cardiorespiratory manifestations
Time frame: 2 years
the oral feeding performance
Assistance Publique Hopitaux De Marseille
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04932044
Preterm Infants, Quality of Life
Taipei, Taiwan
View Trial DetailsNCT07470398
Neurologic Manifestations, Pain
Karbala, Kerbala, Iraq
View Trial DetailsNCT07245277
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Bandung, West Java, Indonesia
View Trial DetailsNCT07207161
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Konya, Meram, Turkey (Türkiye)
View Trial Details